Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 12 - 05 crawled time : 14:00 save search
Medtronic completes enrollment in pivotal trial evaluating first-of-its-kind pulsed field ablation catheter for patients with atrial fibrillation
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: -0.73%
H: 0.48%
C: -0.32%
trial
RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
RSPI | $0.0009 0.0% 1.2M
|
Manufacturing
|
| O: 0.0%
H: 52.5%
C: 52.5%
pharmaceuticals stroke collaboration neurological
Cogent Biosciences to Host Investor Webcast to Discuss Updated Clinical Data at ASH from the Ongoing Phase 2 APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
COGT | $6.545 -5.96% -6.34% 1.5M
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: -3.47%
ongoing bezuclastinib trial
First Patients in the World Treated with Impella RP Flex with SmartAssist
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%
|
Health Technology
|
| O: 0.08%
H: 0.36%
C: 0.27%
Dermata Announces Topline Results from DMT310 Phase 2 Clinical Trial for the Treatment of Moderate-to-Severe Rosacea
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
DRMA | $0.3397 -2.75% 17K
|
|
| O: -58.94%
H: 9.51%
C: -2.28%
dmt310 treatment topline trial phase 2
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
OMCL | News | $27.45 -3.45% -3.57% 440K
|
Technology Services
|
| O: -0.61%
H: 0.08%
C: -2.14%
management services
Definitive Healthcare named a 2022 Top Place to Work by The Boston Globe for sixth consecutive year
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
DH | $7.24 -0.41% -0.41% 690K
|
Professional, Scientific, and T...
|
| O: -1.69%
H: 0.74%
C: 0.08%
work year
Verizon continues to deploy 5G Ultra Wideband faster than expected
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
VZ | News | $39.49 -0.53% 0.36% 16M
|
Communications
|
| O: -0.52%
H: 0.34%
C: -2.4%
expected
Hepion Pharmaceuticals Announces Early Completion of Enrollment in Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K
|
Health Technology
|
| O: 1.13%
H: 6.63%
C: -0.88%
pharmaceuticals liver trial phase 2
Financial House Joins LPL Financial
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
XYF | News | $3.815 -1.74% 0.39% 5.4K
|
Finance
|
| O: 1.0%
H: 0.0%
C: -0.43%
LPLA | News | $264.63 -0.85% -0.86% 380K
|
Finance
|
| O: -2.0%
H: 0.2%
C: -3.28%
financial house
CCell wins Power System Product of the Year at Elektra Awards
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
VICR | $32.06 -8.87% -9.73% 690K
|
Electronic Technology
|
| O: -0.34%
H: 1.05%
C: -1.22%
awards system
GOGL - Transactions made under the buy-back programme
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
GOGL | $13.57 1.42% 1.4% 1.6M
|
Transportation
|
| O: 4.12%
H: 3.67%
C: -2.68%
Celularity Announces Halal Certification of its Advanced Cellular Therapeutics, Biomaterial Products and Business Model
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
CELU | News F | $3.385 5.45% 5.17% 36K
|
|
| O: -1.14%
H: 2.89%
C: -2.31%
certification
Jazz Pharmaceuticals Presents New Findings From Caregiver Survey on Outcomes of Epidiolex® (cannabidiol) for Adult and Pediatric Patients With Severe, Childhood-Onset Epilepsies
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
JAZZ | $108.38 -1.18% -1.19% 400K
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: -3.81%
epidiolex pharmaceuticals
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
ENLV | News | $1.52 15.15% 13.16% 130K
|
Health Technology
|
| O: 0.0%
H: 1.79%
C: -1.35%
financial update results
iSpecimen Appoints Joseph J. Basile to Board of DirectorsSought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Restructuring and Governance to iSpecimen
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
ISPC | $0.2772 -6.07% -6.46% 280K
|
Professional, Scientific, and T...
|
| O: -3.92%
H: 2.72%
C: 1.36%
Arbe to Host Investor and Analyst Meetings at CES 2023
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
ARBE | $1.8 -1.1% -1.11% 28K
|
|
| O: 1.19%
H: 2.36%
C: -4.13%
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
NDRA | $0.2546 0.08% 0.08% 42K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: -11.3%
sciences life
Jaguar Health Subsidiary Napo Pharmaceuticals Sponsors Episode of The Gayly Dose Focused on HIV-related Diarrhea
Published: 2022-12-05 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M
|
Health Technology
|
| O: 1.46%
H: 0.16%
C: -6.97%
pharmaceuticals diarrhea health hiv
Los Angeles Rams and ARound Introduce the Next Generation of Stadium Augmented Reality, Sponsored by SoFi
Published: 2022-12-05 (Crawled : 14:00) - prnewswire.com
STGW 4 | $6.07 1.0% 0.99% 410K
|
|
| O: -0.8%
H: 2.29%
C: 0.81%
angeles
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.